Suppr超能文献

在口咽鳞状细胞癌中,PD-L1 和 TIL 评估中材料和方法选择的重要性。

Importance of choice of materials and methods in PD-L1 and TIL assessment in oropharyngeal squamous cell carcinoma.

机构信息

Department of Medical Oncology, Ghent University Hospital, Ghent, Belgium.

Department of Pathology, Ghent University Hospital, Ghent, Belgium.

出版信息

Histopathology. 2018 Sep;73(3):500-509. doi: 10.1111/his.13650. Epub 2018 Jul 4.

Abstract

AIMS

A great deal of research is being conducted into PD-L1 immunohistochemistry (IHC) and tumour-infiltrating lymphocytes (TILs) as predictive or prognostic biomarkers for immunotherapy, although several practical issues exist concerning their assessment. The aim of this research was therefore to assess the importance of choice of materials and methods in PD-L1 and TILs scoring in oropharyngeal squamous cell carcinoma (OSCC).

METHODS AND RESULTS

IHC for PD-L1 (SP142 and 22C3 clone) and TILs subtyping was performed on formalin-fixed paraffin-embedded tissue slides (biopsy, resection and/or lymph nodes specimens) of 99 patients with OSCC. A comparative analysis of PD-L1 and TILs scoring was made between different types of tissue specimens, between different PD-L1 clones, between TILs and different subsets of TILs and between the quantitative and semiquantitative assessments. PD-L1 scoring resulted in fair to moderate agreement for 22C3 and SP142 between various tissue specimens, with higher agreement at higher cut-off values, and in moderate agreement for 22C3 versus SP142. Evaluation by four independent observers proved substantial inter-rater agreement for both clones with high consistency in their ratings. Moderate agreement was observed for TILs and TILs subsets for the comparison between biopsy and resection. Lastly, strong correlations were found between quantitative and semiquantitative assessment for all PD-L1 and TILs scores.

CONCLUSIONS

Our results highlight the challenges associated with the evaluation of PD-L1 and TILs in OSCC. Further research is warranted to evaluate the use of these biomarkers in order to allow implementation of PD-L1 and TILs infiltrate as biomarkers in daily clinical practice.

摘要

目的

大量研究正在进行 PD-L1 免疫组织化学(IHC)和肿瘤浸润淋巴细胞(TILs)作为免疫治疗的预测或预后生物标志物,尽管在评估方面存在一些实际问题。因此,本研究旨在评估选择材料和方法在口咽鳞状细胞癌(OSCC)中 PD-L1 和 TILs 评分中的重要性。

方法和结果

对 99 例 OSCC 患者的福尔马林固定石蜡包埋组织切片(活检、切除和/或淋巴结标本)进行 PD-L1(SP142 和 22C3 克隆)和 TILs 亚型 IHC。对不同类型的组织标本、不同的 PD-L1 克隆、TILs 与不同的 TILs 亚群以及定量和半定量评估之间的 PD-L1 和 TILs 评分进行了比较分析。22C3 和 SP142 在各种组织标本之间的 PD-L1 评分结果具有中等至良好的一致性,在较高的截止值下具有更高的一致性,并且 22C3 与 SP142 的一致性中等。四位独立观察者的评估结果表明,两种克隆均具有较高的观察者间一致性,且评分具有高度一致性。活检与切除之间的 TILs 和 TILs 亚群的评估结果具有中等一致性。最后,所有 PD-L1 和 TILs 评分的定量和半定量评估之间均存在强相关性。

结论

我们的研究结果强调了在 OSCC 中评估 PD-L1 和 TILs 所面临的挑战。需要进一步的研究来评估这些生物标志物的使用,以便在日常临床实践中实现 PD-L1 和 TILs 浸润作为生物标志物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验